Top Markets
Coin of the day
UnicoCell Biomed Co., Ltd. UnicoCell Biomed Co., Ltd.

UnicoCell Biomed Co., Ltd.

6794
Rank in Stocks #19525
UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the... UnicoCell Biomed Co., Ltd., a Taiwanese enterprise, specializes in the research, development, and application of stem cell-based pharmaceuticals, advanced cell therapy techniques, and regenerative medical solutions. Their flagship product, ELIXCYTE, is presently undergoing Phase 2 clinical trials, targeting both osteoarthritis and chronic kidney disease. Beyond therapeutics, the company also offers UnicoVial, a specialized cryopreservation and drug containment system designed for cell therapy products, and provides a range of related testing services.
Share Price
$2.54
Market Cap
$161.89M
Change (1 day)
5.96%
Change (1 year)
1.63%
Country
TW
Trade UnicoCell Biomed Co., Ltd. (6794)

Category

Number of shares outstanding for UnicoCell Biomed Co., Ltd. (6794)
Number of shares outstanding as of August 2026: 0
According to UnicoCell Biomed Co., Ltd. latest financial reports and stock price the company's current number of shares outstanding is 0. At the end of August 2026 the company had 0 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for UnicoCell Biomed Co., Ltd. (6794) from 2026 to 2026
Shares Outstanding at the end of each year
Year Shares Outstanding Change
Not enough data for the provided dates.
Shares Outstanding for similar companies or competitors
Company Shares Outstanding Difference Country
253.90M -
US
62.19M -
NL
396.00M -
US
478.91M -
AU
- -
CH